Blood cancers

Monoclonal antibodies in multiple myeloma: helping us to take back control of the immune system

Sponsored by Janssen-Cilag Pty Ltd

Professor Saad Usmani from the Levine Cancer Institute in Charlotte, North Carolina gave delegates attending the Janssen H3 medical education symposium in Melbourne an overview of the diverse strategies by which monoclonal antibodies (MAbs) are helping to tackle multiple myeloma (MM). “As our understanding of myeloma biology has expanded, we’re in a position where we ...

Already a member?

Login to keep reading.

© 2021 the limbic